News by Tag: Regulatory Affairs


Synowledge to Exhibit at 25th Annual DIA EuroMeeting
February 25, 2013
Synowledge, LLC is pleased to announce that it will exhibit at the 25th Annual Drug Information Association (DIA) EuroMeeting in Amsterdam, Netherlands on March 4-6th, 2013.
Synowledge Launches Life Sciences and IT Webinar Series
February 25, 2013
Synowledge, LLC is pleased to announce the launch of its free Synowledge Webinar Series encompassing relevant industry topics in pharmacovigilance, regulatory affairs, and IT.
Synowledge, LLC Experiences Record Growth in 2012
January 16, 2013
Synowledge, LLC is pleased to announce record growth in 2012, with the addition of over 20 new clients, including several Top 20 Global Biotech/Pharma companies.
Synowledge LLC Opens New Office in New York City
January 9, 2013
Synowledge, LLC is pleased to announce the opening of a new office in Manhattan, New York City in order to better accommodate its clients and further expand its global reach.
MakroCare Exhibiting at RAPS 2012 in Seattle, USA
October 16, 2012
MakroCare exhibiting at 2012 RAPS: The Regulatory Convergence, in Seattle, USA from October 26 to October 30.
ComplianceOnline Announces Interactive Workshop on Design Control for Medical Devices
August 9, 2012
ComplianceOnline, the leading GRC advisory network, and well known regulatory affairs expert Dr. David Lim, will conduct a day long, interactive workshop on design control for medical devices, including in vitro diagnostic devices.
ArisGlobal's New Generation Pharmacovigilance and Clinical Safety Solution Goes Live at Mitsubishi Tanabe Pharma Corporation
August 6, 2012
Major Upgrade Enables Organization to Submit Safety Reports to All Major Authorities Worldwide From a Single, Integrated Database and Web Application
Synowledge to Showcase its Entire Suite of Life Sciences Solutions at the 48th DIA Annual Meeting in Philadelphia
May 28, 2012
Synowledge is a global provider of drug safety, regulatory affairs and related IT solutions to small, mid and large sized pharmaceutical and biotechnology companies.